Global

Keypoints: The FDA granted accelerated approval to Asciminib for the treatment of patients with Philadelphia chromosome-positive chronic myeloid leukemia for 2 indications.…

The European Commission has cleared Keytruda (Pembrolizumab) in combination with chemotherapy as a first-line treatment for locally recurrent, unresectable or metastatic TNBC…

NPPA fixed the ceiling prices for 12 anti-diabetic generic medicines, including Glimepiride tablets, glucose injection and intermediate acting insulin solution. Drug price…

  Bausch Health Companies Inc and Clearside Biomedical Inc said on Monday they received approval from the U.S. health regulator for their…

Keypoints Albaugh announced the EPA registration of Anchor™ 3L ST in multiple crop segments as a new fungicide seed treatment offer. Anchor™…

This information is provided to assist you if you are new to engaging with the TGA and Australia’s regulatory framework for medical…

Keypoints USFDA approves Roche’s Tecentriq as adjuvant treatment for certain people with early NSCLC Tecentriq treatment reduced the risk of disease recurrence…

Key Points –   AION Labs, a first-of-its-kind innovation lab spearheading the adoption of AI technologies and computational science to solve therapeutic challenges,…

Key Point –  Aceto Pharma to acquire GMP of A&C Bio Buffer ltd  Aceto will continue to support A&C BioBuffer’s manufacturing facilities and offices…